Skip to content
Study details
Enrolling now

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

University of North Carolina, Chapel Hill
NCT IDNCT05282277ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

103

Study length

about 4.7 years

Ages

45–55

Sex

Female only

Locations

1 site in NC

What this study is about

Researchers are testing whether estradiol, a hormone, affects brain function in women experiencing anhedonia (loss of interest), depression, or psychosis. The trial will use imaging techniques to see how estradiol impacts the brain's response to rewards.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Matching Placebo Patch
  • 2.Take Micronized Progesterone
  • 3.Take Raclopride C11
  • +1 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
transdermalOral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Progestational Hormone Receptor Agonists), estradiol

Drug routes

transdermal, oral (Oral Capsule), oral (Oral Tablet)

Endpoints

Secondary: Changes in PO Psychosis Symptoms following Estradiol Administration Using the BPRS

Body systems

Psychiatry / Mental Health